Featured Posts
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring…
Blog
Don’t hinder biosimilar development
In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing.
Search Posts
Newsletter
Fannie Mae, HIV Rates and Greenhouse Gases
Mortgage giant Fannie Mae announces a shakeup of its senior management. A new study finds New York City’s HIV infection rate to be three times…
Newsletter
West Nile, Union Corruption and Federal Courts
The West Nile Virus has infected individuals in 28 states so far this year. The Los Angeles Times publishes a 3-part series on corruption allegations…
Op-Eds
Sick Patients Need Cutting-Edge Drugs
The story of Anna Tomalis trying to recieve a compassionate usage exemption from the FDA to treat her cancer.
Newsletter
Drug Approval at the FDA, Childhood Obesity and the War on Bottled Water
Industry analysts characterize the Food and Drug Administration’s drug approval process as especially “conservative.” An anti-obesity advertising campaign targeted at children generates controversy. Local government…
News Release
Reform Needed at the Food and Drug Administration
Washington, D.C., August 14, 2008—In order to best serve the interests of the nation’s patients and doctors, the structure of the…
Newsletter
Global Warming Apathy, Pelosi on Oil Drilling and Government Health Care
A new survey suggests that public concern about global warming is on the decline. House Speaker Nancy Pelosi reverses her opposition to a vote on…